NABI BIOPHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NABI BIOPHARMACEUTICALS CMN, CUSIP 629519109.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NABI BIOPHARMACEUTICALS CMN, CUSIP 629519109.